Polley, S., Conway, D., Cavanagh, D., McBride, J., Lowe, B., Williams, T., . . . Marsh, K. (2006). High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.

Polley, S., D. Conway, DR Cavanagh, J. McBride, B. Lowe, T. Williams, T. Mwangi, and K. Marsh. High Levels of Serum Antibodies to Merozoite Surface Protein 2 of Plasmodium Falciparum Are Associated with Reduced Risk of Clinical Malaria in Coastal Kenya. 2006.

Polley, S., et al. High Levels of Serum Antibodies to Merozoite Surface Protein 2 of Plasmodium Falciparum Are Associated with Reduced Risk of Clinical Malaria in Coastal Kenya. 2006.